General Information of DTT (ID: TTG6LA7)

DTT Name Activation-inducible TNFR family receptor (TNFRSF18) DTT Info
Gene Name TNFRSF18

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
8 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
INCAGN01876 DMNUXKA Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
INCAGN1876 DM8XN4A Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]
TRX-518 DMQS5DY Solid tumour/cancer 2A00-2F9Z Phase 1/2 [3]
AMG 228 DMLQJ5P Solid tumour/cancer 2A00-2F9Z Phase 1 [4]
ASP1951 DMX4PWV Solid tumour/cancer 2A00-2F9Z Phase 1 [5]
MK-4166 DML5V76 Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
REGN6569 DM0ZMNI Squamous head and neck cell carcinom 2D60.0 Phase 1 [7]
TRX518 DM9IDUH Solid tumour/cancer 2A00-2F9Z Phase 1 [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Clinical Trial Drug(s)
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Agenus.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Immuno-oncology moves beyond PD-1. Nat Biotechnol. 2015 Jul;33(7):673-5.
4 Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors. J Immunother Cancer. 2018 Sep 25;6(1):93.
5 ClinicalTrials.gov (NCT03799003) A Study of ASP1951 in Subjects With Advanced Solid Tumors. U.S. National Institutes of Health.
6 Immuno-oncology moves beyond PD-1. Nat Biotechnol. 2015 Jul;33(7):673-5.
7 Clinical pipeline report, company report or official report of Regeneron Pharmaceuticals.
8 Clinical pipeline report, company report or official report of Leap Therapeutics.